These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Malignancies in patients treated with high doses of radium-224. Nekolla EA, Kellerer AM, Kuse-Isingschulte M, Eder E, Spiess H. Radiat Res; 1999 Dec; 152(6 Suppl):S3-7. PubMed ID: 10564925 [Abstract] [Full Text] [Related]
3. Radiation-induced sarcomas of bone. Brady LW. Skeletal Radiol; 1979 Jun 06; 4(2):72-8. PubMed ID: 388642 [Abstract] [Full Text] [Related]
5. Pathology of radiation-induced bone tumors. Gössner W. Leuk Res; 1986 Jun 06; 10(7):897-904. PubMed ID: 3461224 [Abstract] [Full Text] [Related]
6. Dose and dose-rate dependence for bone sarcomas in radium-224 patients. Kellerer AM, Spiess H, Chmelevsky D. Int J Radiat Biol; 1990 Nov 06; 58(5):864-6. PubMed ID: 1977830 [No Abstract] [Full Text] [Related]
7. Life-span study on late effects of 224Ra in children and adults. Spiess H. Health Phys; 2010 Sep 06; 99(3):286-91. PubMed ID: 20699688 [Abstract] [Full Text] [Related]
8. Radiation-induced systemic and local bone tumors: two types of late effects with possible different origins? Müller WA, Luz A, Linzner U. Radiat Res; 1994 Jun 06; 138(3):415-22. PubMed ID: 8184017 [Abstract] [Full Text] [Related]
9. Bone sarcoma cumulative tumor rates in patients injected with 224Ra. Mays CW, Spiess H, Chmelevsky D, Kellerer A. Strahlentherapie Sonderb; 1985 Jun 06; 80():27-31. PubMed ID: 4095733 [No Abstract] [Full Text] [Related]
10. Induction of malignant bone tumors in radium-224 patients: risk estimates based on the improved dosimetry. Nekolla EA, Kreisheimer M, Kellerer AM, Kuse-Isingschulte M, Gössner W, Spiess H. Radiat Res; 2000 Jan 06; 153(1):93-103. PubMed ID: 10630982 [Abstract] [Full Text] [Related]
11. Target cells in internal dosimetry. Gössner W. Radiat Prot Dosimetry; 2003 Jan 06; 105(1-4):39-42. PubMed ID: 14526924 [Abstract] [Full Text] [Related]
13. The reverse protraction factor in the induction of bone sarcomas in radium-224 patients. Chmelevsky D, Spiess H, Mays CW, Kellerer AM. Radiat Res; 1990 Oct 06; 124(1 Suppl):S69-79. PubMed ID: 2236514 [Abstract] [Full Text] [Related]
14. Bone sarcoma characteristics and distribution in beagles injected with radium-226. White RG, Raabe OG, Culbertson MR, Parks NJ, Samuels SJ, Rosenblatt LS. Radiat Res; 1994 Mar 06; 137(3):361-70. PubMed ID: 8146280 [Abstract] [Full Text] [Related]
16. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, de Vathaire F. Breast Cancer Res Treat; 2005 Feb 06; 89(3):277-88. PubMed ID: 15754127 [Abstract] [Full Text] [Related]
17. [Radiation pathology of the skeletal system]. Gössner W. Fortschr Geb Rontgenstr Nuklearmed; 1972 Feb 06; ():Suppl:145-6. PubMed ID: 4344539 [No Abstract] [Full Text] [Related]
18. [Malignant tumors of the bone and soft tissues developing following radiotherapy in the areas of exposure]. Kiyono K, Moriya K, Watanabe T, Kobayashi T. Gan No Rinsho; 1982 Feb 06; 28(2):146-50. PubMed ID: 6963594 [No Abstract] [Full Text] [Related]
19. Incidence of malignant diseases in humans injected with radium-224. Nekolla EA, Walsh L, Spiess H. Radiat Res; 2010 Sep 06; 174(3):377-86. PubMed ID: 20726727 [Abstract] [Full Text] [Related]